Quironsalud Madrid
| Turchia | Austria | Spagna | |
| Radioterapia per il cancro colorettale | da $7,000 | da $12,000 | da $10,000 |
| Radiochirurgia stereotassica | da $4,500 | da $17,000 | da $12,000 |
| Craniotomia | da $5,650 | da $20,000 | da $25,000 |
| Chemioterapia per carcinoma mammario | da $1,200 | da $15,000 | da $3,500 |
| Halcyon | da $5,400 | - | - |
Pioniere nella pianificazione chirurgica 3D con oltre 30 anni di eccellenza, il Dr. Herrero integra tecnologie avanzate per precisione nella chirurgia plastica e ricostruttiva.
Il Dr. Oliver è un neurochirurgo di fama mondiale con oltre 40 anni di esperienza e più di 1.100 trattamenti effettuati. Si specializza in chirurgia mini-invasiva per tumori cerebrali come l'astrocitoma.
Il medico ha concentrato la sua ricerca sulle sindromi neurologiche paraneoplastiche, guidando un panel che ha stabilito i criteri diagnostici. Il suo lavoro ha confermato l'ipotesi immunitaria che collega i tumori a disfunzioni neurologiche autoimmuni, con anticorpi identificati da lui ora essenziali per la diagnosi.<\/p>
Clinicamente, il medico è specializzato nella diagnosi e gestione di gliomi, linfomi cerebrali primari e neurotossicità correlate al trattamento del cancro. Gli interessi recenti includono complicazioni neurologiche da inibitori dei checkpoint immunitari e trapianto di cellule staminali ematopoietiche.<\/p>
Ha conseguito un MD e un PhD presso l'Universitat Autónoma de Barcelona, ha completato una residenza in neurologia a Barcellona e una borsa di studio in neuro-oncologia presso il Memorial Sloan-Kettering Cancer Center.<\/p>
Il medico è un oncologo pediatrico con 37 anni di esperienza, specializzato nel trattamento dei disturbi del sangue e nell'esecuzione di procedure come i trapianti di midollo osseo e la terapia ablativa. Attualmente, il medico è Capo dell'Emato-Oncologia Pediatrica presso l'Ospedale Universitario Quironsalud Madrid.<\/p>
Con un prolifico curriculum accademico, il medico ha curato 14 libri, contribuito a 75 capitoli di libri e presentato a oltre 200 conferenze. Il medico è membro di diverse associazioni professionali, tra cui l'Associazione Spagnola di Ematologia Pediatrica e l'Associazione Spagnola di Oncologia Pediatrica.<\/p>
Il medico tratta un'ampia gamma di condizioni, tra cui leucemia, linfoma, mieloma multiplo e vari disturbi ematologici e autoimmuni.<\/p>
Spain offers elite neuro-oncology care at JCI-accredited centers in Barcelona and Madrid. Leading facilities like Centro Médico Teknon and Hospital Quiron Barcelona utilize fluorescence-guided surgery and robotic mapping. Specialized pediatric care is available at SJD Barcelona Children Hospital for patients under 18 years.
Bookimed Expert Insight: Data shows that Barcelona is the primary hub for specialized astrocytoma care. Centro Médico Teknon stands out for high-complexity cases due to its specialized Brain Tumor Center. While Madrid facilities like Quiron Madrid offer participation in oncology clinical trials, Teknon is frequently selected by high-profile patients for its privacy and specialized neurosurgical equipment like the Mazor Robotics system. For pediatric cases, SJD Barcelona Children Hospital is a top European institution, treating over 4,000 children annually.
Patient Consensus: Patients emphasize finding a hospital with a dedicated brain-tumor team rather than just choosing by city. They note the importance of quick access to repeat MRI scans and molecular testing during long-term recovery.
Specialized astrocytoma treatments in Spain for 2026 focus on fluorescence-guided microsurgery and advanced robotic radiosurgery using MR-Linac and Truebeam technologies. JCI-accredited centers in Barcelona and Madrid prioritize maximum tumor resection while preserving motor functions through real-time neuronavigation and intraoperative mapping.
Bookimed Expert Insight: Data shows a clear distinction between academic centers like Clínica Universidad de Navarra and surgical hubs like Centro Médico Teknon. Patients often choose Teknon for Dr. Bartolome Oliver, who performs over 200 annual neurosurgeries with a focus on robotic-assisted techniques. While large university platforms offer higher clinical trial access, boutique centers like Teknon provide faster coordination for non-invasive Truebeam radiosurgery, often starting treatments within days of the initial consultation.
Patient Consensus: Patients emphasize the necessity of requesting full molecular profiling and a tumor board review early in the process. Many note that confirming a clinic's ability to perform awake craniotomy is vital for tumors located near language centers.
Surgery in Spain serves as the primary treatment for astrocytoma. Specialist neurosurgeons prioritize maximal safe resection to remove tumor mass while preserving neurological function. Experts use advanced technologies like fluorescence-guided surgery to identify diffuse tumor margins. Procedures conform to Spanish Society of Medical Oncology standards.
Bookimed Expert Insight: Analysis of clinical data in Spain shows a strong concentration of expertise in Barcelona and Madrid. While many centers offer standard craniotomy, clinics like Centro Médico Teknon differentiate through specialized volume. Dr. Bartolome Oliver performs over 200 annual operations and uses fluorescence-guided techniques. This high procedural volume is a key indicator of surgical precision in complex neuro-oncology cases.
Patient Consensus: Patients emphasize that surgery is just the first step in a longer multidisciplinary journey. Many note that waiting for pathology results is the hardest part, as these molecular findings dictate the subsequent radiation or chemotherapy plan.
Proton therapy for astrocytoma is not widely available in Spain. It is accessible at specialized centers primarily in Madrid. These facilities utilize systems like Proteus ONE to treat central nervous system tumors. Most patients still receive traditional radiation at regional oncology hubs.
Bookimed Expert Insight: While Madrid is the hub for proton therapy, Barcelona centers like Centro Médico Teknon report high volumes for alternative radiosurgery. Dr. Bartolome Oliver alone performs over 200 operations annually. If proton therapy is unavailable, these JCI-accredited clinics offer comparable precision with MR-Linac or Novalis systems.
Patient Consensus: Patients note that access often requires traveling to major cities or other regions. They emphasize that standard radiotherapy remains the most accessible option at local hospitals.
International patients enroll in Spanish astrocytoma trials by submitting molecular pathology reports to specialized neuro-oncology units. Centers like Quironsalud Madrid offer clinical trial infrastructure with potential for free treatment. Eligibility requires meeting strict inclusion criteria. Enrollment follows a structured medical review process.
Bookimed Expert Insight: Spain ranks 4th globally in clinical trial demand for brain tumors at Bookimed. Quironsalud Madrid stands out by offering free treatment for qualifying trial participants. This is a rare benefit compared to standard European oncology care. Patients should prioritize clinics with integrated research centers like the Baselga Institute at Hospital Quiron Barcelona.
Patient Consensus: Patients note that medical records must include detailed molecular profiling to avoid screening failures. Long-term travel for follow-up scans is often the greatest practical challenge during the trial.
Astrocytomas range from benign grade 1 tumors to malignant grade 4 glioblastomas. Spanish centers like Centro Médico Teknon and Clínica Universidad de Navarra successfully cure most grade 1 cases through surgery. Grade 2-4 cases require long-term management using Truebeam radiosurgery and molecular-targeted therapies.
Bookimed Expert Insight: While many search for general neurosurgery, the most successful outcomes in Spain are found at JCI-accredited centers combining imaging and radiation. For example, Centro Médico Teknon offers specialized packages for stereotactic radiosurgery around $17,000. These clinics often participate in international clinical trials. This gives patients access to emerging protocols not available at standard hospitals. Choosing a high-volume center is vital as specialists there see hundreds of rare tumor subtypes annually.
Patient Consensus: Patients emphasize that a cure often means no recurrence on scans for several years rather than a one-time fix. They note that the tumor's molecular markers are just as important as the grade for planning treatment.
Patients treating astrocytoma in Spain should expect manageable side effects like fatigue, cerebral edema, and nausea. Modern neuro-oncology centers typically use fluorescence-guided surgery to protect speech and motor functions. Treatment plans often combine chemotherapy with non-invasive radiosurgery to preserve healthy brain tissue and reduce long-term cognitive impact.
Bookimed Expert Insight: Spanish oncology centers like Centro Médico Teknon frequently use MR-Linac technology for radiosurgery. This allows Dr. Bartolome Oliver to adjust radiation beams in real-time as the brain shifts. These precision adjustments help prevent the late-stage radiation necrosis often seen with older equipment. This technology significantly improves the preservation of short-term memory and concentration after treatment.
Patient Consensus: Patients note that keeping a daily log of seizures and mood helps their Spanish medical team adjust steroid dosages much faster. While fatigue feels heavier than expected, many emphasize that anti-nausea medications make chemotherapy cycles surprisingly manageable.